Solcoderm as a tool for the plastic surgeon. The treatment of verrucae.
In 243 cases of verruca vulgaris, about 85% of the epidermal efflorescences caused by the wart virus were cured by two or more applications of Solcoderm in ambulant therapy. Of 127 cases of verruca plantaris treated, about 70% were cured after an initial course of four applications and 80% after further courses of treatment. More than 80% of recurrences responded to retreatment. A favorable effect on the pain caused by the plantaris warts was reported by 95% of the patients treated. No delayed complications were observed after the use of Solcoderm. The rate of incapacity for work after Solcoderm treatment, a total of 41 man-days, was extremely low when compared with that following cryosurgery and other surgical measures which, unlike Solcoderm therapy, often require immobilization, dressings or avoidance of soap and water.
D000085:Acetates / Q000009:adverse effects / Q000627:therapeutic use; D019342:Acetic Acid; D000971:Antineoplastic Combined Chemotherapy Protocols; D003131:Combined Modality Therapy; D003300:Copper / Q000009:adverse effects / Q000627:therapeutic use; D003879:Dermatologic Agents / Q000009:adverse effects / Q000627:therapeutic use*; D004338:Drug Combinations / Q000009:adverse effects / Q000627:therapeutic use; D005533:Foot Dermatoses / Q000473:pathology / Q000628:therapy*; D006229:Hand Dermatoses / Q000473:pathology / Q000628:therapy*; D006801:Humans; D007773:Lactates / Q000009:adverse effects / Q000627:therapeutic use; D009566:Nitrates / Q000009:adverse effects / Q000627:therapeutic use; D013518:Surgery, Plastic / Q000379:methods*; D014860:Warts / Q000473:pathology / Q000628:therapy*
D000085:Acetates; D003879:Dermatologic Agents; D004338:Drug Combinations; D007773:Lactates; D009566:Nitrates; D003300:Copper; D019342:Acetic Acid